BIOMAT Database Logo BIOMAT Database Logo

EEG sleep, lithium transport, dexamethasone suppression, and monoamine oxidase activity in borderline personality disorder. 1988

H W Lahmeyer, and E Val, and F M Gaviria, and R B Prasad, and G N Pandey, and P Rodgers, and M A Weiler, and E G Altman
Dept. of Psychiatry, University of Illinois, Chicago 60680.

Twenty-one patients who met DSM-III criteria for borderline personality disorder (BPD) and also scored at least 7 on the Diagnostic Interview for Borderlines (DIB) were assessed on four biological markers: electroencephalographic (EEG) sleep, in vitro lithium ratio, platelet monoamine oxidase (MAO), and dexamethasone suppression test (DST). REM latency averaged 58.66 (SD 14.39); platelet MAO averaged 21.74 (SD 10.33); and lithium ratio was 0.357 (SD 0.139) in the BPD patients. All of those values were significantly abnormal. Many patients had abnormalities on three or four measures. These patients in general had multiple Axis I diagnoses from the Diagnostic Interview Schedule (DIS), and these Axis I diagnoses tended to produce patient clusters. Patients with a DIS diagnosis of schizophrenia, mania, hypomania, or schizoaffective mania had elevated lithium, low MAO, and normal EEG sleep, while those patients with coexisting major depression tended to have short rapid eye movement (REM) latency, high REM density, and normal MAO and lithium ratio. Only two patients were nonsuppressors on the DST, confirming recent reports of normal DST results in personality disorders.

UI MeSH Term Description Entries
D008094 Lithium An element in the alkali metals family. It has the atomic symbol Li, atomic number 3, and atomic weight [6.938; 6.997]. Salts of lithium are used in treating BIPOLAR DISORDER. Lithium-7,Lithium 7
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008995 Monoamine Oxidase An enzyme that catalyzes the oxidative deamination of naturally occurring monoamines. It is a flavin-containing enzyme that is localized in mitochondrial membranes, whether in nerve terminals, the liver, or other organs. Monoamine oxidase is important in regulating the metabolic degradation of catecholamines and serotonin in neural or target tissues. Hepatic monoamine oxidase has a crucial defensive role in inactivating circulating monoamines or those, such as tyramine, that originate in the gut and are absorbed into the portal circulation. (From Goodman and Gilman's, The Pharmacological Basis of Therapeutics, 8th ed, p415) EC 1.4.3.4. Amine Oxidase (Flavin-Containing),MAO,MAO-A,MAO-B,Monoamine Oxidase A,Monoamine Oxidase B,Type A Monoamine Oxidase,Type B Monoamine Oxidase,Tyramine Oxidase,MAO A,MAO B,Oxidase, Monoamine,Oxidase, Tyramine
D010554 Personality Disorders A major deviation from normal patterns of behavior. Avoidant Personality Disorder,Impulse-Ridden Personality,Inadequate Personality,Avoidant Personality Disorders,Impulse Ridden Personality,Personality Disorder,Personality Disorder, Avoidant,Personality Disorders, Avoidant,Personality, Impulse-Ridden,Personality, Inadequate
D011930 Reaction Time The time from the onset of a stimulus until a response is observed. Response Latency,Response Speed,Response Time,Latency, Response,Reaction Times,Response Latencies,Response Times,Speed, Response,Speeds, Response
D001883 Borderline Personality Disorder A personality disorder marked by a pattern of instability of interpersonal relationships, self-image, and affects, and marked impulsivity beginning by early adulthood and present in a variety of contexts. (DSM-IV) Personality Disorder, Borderline,Disorder, Borderline Personality,Borderline Personality Disorders,Disorders, Borderline Personality,Personality Disorders, Borderline
D003866 Depressive Disorder An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. Depression, Endogenous,Depression, Neurotic,Depression, Unipolar,Depressive Syndrome,Melancholia,Neurosis, Depressive,Unipolar Depression,Depressions, Endogenous,Depressions, Neurotic,Depressions, Unipolar,Depressive Disorders,Depressive Neuroses,Depressive Neurosis,Depressive Syndromes,Disorder, Depressive,Disorders, Depressive,Endogenous Depression,Endogenous Depressions,Melancholias,Neuroses, Depressive,Neurotic Depression,Neurotic Depressions,Syndrome, Depressive,Syndromes, Depressive,Unipolar Depressions
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D004569 Electroencephalography Recording of electric currents developed in the brain by means of electrodes applied to the scalp, to the surface of the brain, or placed within the substance of the brain. EEG,Electroencephalogram,Electroencephalograms

Related Publications

H W Lahmeyer, and E Val, and F M Gaviria, and R B Prasad, and G N Pandey, and P Rodgers, and M A Weiler, and E G Altman
Low platelet monoamine oxidase activity in borderline personality disorder.
December 1989, Psychiatry research,
H W Lahmeyer, and E Val, and F M Gaviria, and R B Prasad, and G N Pandey, and P Rodgers, and M A Weiler, and E G Altman
Monoamine Oxidase A in Antisocial Personality Disorder and Borderline Personality Disorder.
January 2017, Current behavioral neuroscience reports,
H W Lahmeyer, and E Val, and F M Gaviria, and R B Prasad, and G N Pandey, and P Rodgers, and M A Weiler, and E G Altman
Effects of carbamazepine on dexamethasone suppression and sleep electroencephalography in borderline personality disorder.
January 2002, Neuropsychobiology,
H W Lahmeyer, and E Val, and F M Gaviria, and R B Prasad, and G N Pandey, and P Rodgers, and M A Weiler, and E G Altman
The dexamethasone suppression test in borderline personality disorder.
July 1984, Biological psychiatry,
H W Lahmeyer, and E Val, and F M Gaviria, and R B Prasad, and G N Pandey, and P Rodgers, and M A Weiler, and E G Altman
TRH stimulation and dexamethasone suppression in borderline personality disorder.
September 1996, Biological psychiatry,
H W Lahmeyer, and E Val, and F M Gaviria, and R B Prasad, and G N Pandey, and P Rodgers, and M A Weiler, and E G Altman
Personality correlates of platelet monoamine oxidase activity anbd red cell lithium transport.
March 1980, Psychiatry research,
H W Lahmeyer, and E Val, and F M Gaviria, and R B Prasad, and G N Pandey, and P Rodgers, and M A Weiler, and E G Altman
Monoamine oxidase a gene is associated with borderline personality disorder.
June 2007, Psychiatric genetics,
H W Lahmeyer, and E Val, and F M Gaviria, and R B Prasad, and G N Pandey, and P Rodgers, and M A Weiler, and E G Altman
The dexamethasone suppression test and glucocorticoid receptors in borderline personality disorder.
June 1997, Annals of the New York Academy of Sciences,
H W Lahmeyer, and E Val, and F M Gaviria, and R B Prasad, and G N Pandey, and P Rodgers, and M A Weiler, and E G Altman
Dexamethasone suppression test in borderline personality disorder--effects of posttraumatic stress disorder.
October 2005, Psychoneuroendocrinology,
H W Lahmeyer, and E Val, and F M Gaviria, and R B Prasad, and G N Pandey, and P Rodgers, and M A Weiler, and E G Altman
EEG in borderline personality disorder.
October 1988, Biological psychiatry,
Copied contents to your clipboard!